Searched for
REPORT DRUG SALES
How Nvidia CEO Jensen Huang's extramarital affair could cause collateral damage in WashingtonThe affair between Nvidia CEO Jensen Huang and a Chinese businesswoman suspected of spying for Beijing has triggered investigations in the ...- Anthropic targets $90 billion IPO at $1.4 trillion valuationAnthropic PBC is preparing for an initial public offering aiming for a fully diluted valuation of $1.4 trillion. The company plans to raise...
- While the world nursed a hangover, India ordered another roundIndia’s alcohol consumption rose 10% in the first half of 2026, even as volumes across 21 major markets fell 1%, according to IWSR data sha...
- Home Minister Amit Shah sets December 2028 drug-free Gujarat target, a year ahead of national deadlineUnion Home Minister Amit Shah on Monday set December 31, 2028, as the deadline to make Gujarat drug-free, a year ahead of India’s December ...
- Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's LabsIndian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, c...
- For long- and medium-term investors: Cycles turn, principles don’t; 5 large-cap stocks with upside potential of up to 29%These are the stocks that fell the most, so they may bounce back the most if the fund flows return. They are the ones FPI money will target...
- These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
- Zydus Q2 profit falls 27% despite 29% revenue growth; consumer wellness sales surge 76%Zydus Lifesciences reported a 29% year-on-year rise in Q2FY27 revenue to Rs 7,909 crore, driven by growth across key markets and a 76% surg...
- Stocks in news: NSE, BSE, SBI, Happiest Minds, MCX, IEX and Minda CorpThe Indian stock market continues its upward momentum, with the Nifty 50 showing a robust rally and hitting significant resistance levels. ...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Who is Melissa Rycroft? Ex-'Bachelor' star faces fresh DWI arrest months after pleading guilty to previous chargesMelissa Rycroft, former 'Bachelor' star, has been arrested for her second Driving While Intoxicated charge. This latest incident occurred a...
- India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugsOver the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...
- Sun Pharma Q2 profit takes a hit on exceptional itemsSun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue ...
- Sun Pharma Q2 profit falls 36% as litigation costs hit earningsSun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Reven...
- Pan masala ad proceedings against 3 actors complete, matter up for adjudication next: FDA chiefMaharashtra FDA has completed its investigation into actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged violations of state ru...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- Cipla expects US business to draw support from upcoming product pipelineCipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fe...
Load More
